相似文献
1
Updates of colorectal cancer liver metastases therapy: review on DEBIRI.
Hepat Oncol. 2020 Jan 21;7(1):HEP16. doi: 10.2217/hep-2019-0010.
2
Prognostic Value of TACE With Irinotecan-loaded Drug-eluting Beads (DEBIRI) in Patients With Liver Metastases from Unresectable Colorectal Cancer.
Anticancer Res. 2023 Aug;43(8):3647-3651. doi: 10.21873/anticanres.16545.
3
Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
World J Surg. 2016 May;40(5):1178-90. doi: 10.1007/s00268-015-3386-9.
4
Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial.
Clin Res Hepatol Gastroenterol. 2015 Dec;39(6):e73-7. doi: 10.1016/j.clinre.2015.06.004. Epub 2015 Jul 2.
5
Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review.
J Vasc Interv Radiol. 2013 Aug;24(8):1209-17. doi: 10.1016/j.jvir.2013.05.055.
6
Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study.
Ann Surg Oncol. 2011 Jan;18(1):192-8. doi: 10.1245/s10434-010-1288-5. Epub 2010 Aug 26.
7
Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer.
Anticancer Res. 2013 May;33(5):2077-83.
8
Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.
Cancer. 2015 Oct 15;121(20):3649-58. doi: 10.1002/cncr.29534. Epub 2015 Jul 6.
9
Transarterial Chemoembolisation of Colorectal Liver Metastases with Irinotecan-Loaded Beads: A Bi-institutional Analysis of 125 Treatments in 53 Patients.
Cardiovasc Intervent Radiol. 2019 Jul;42(7):979-990. doi: 10.1007/s00270-019-02219-4. Epub 2019 May 1.
10
The Role of Conventional TACE (cTACE) and DEBIRI-TACE in Colorectal Cancer Liver Metastases.
Cancers (Basel). 2022 Mar 15;14(6):1503. doi: 10.3390/cancers14061503.
引用本文的文献
1
Rapid detection of liver metastasis risk in colorectal cancer patients through blood test indicators.
Front Oncol. 2024 Sep 11;14:1460136. doi: 10.3389/fonc.2024.1460136. eCollection 2024.
2
Applications of image-guided locoregional transarterial chemotherapy in patients with inoperable colorectal cancer: a review.
Front Oncol. 2024 Aug 23;14:1464242. doi: 10.3389/fonc.2024.1464242. eCollection 2024.
3
Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases.
Cochrane Database Syst Rev. 2024 Aug 9;8(8):CD012757. doi: 10.1002/14651858.CD012757.pub2.
4
Efficacy and Safety of Liver Chemoembolization Procedures, Combined with FOLFIRI Chemotherapy, in First-Line Treatment of Metastatic Colorectal Cancer in Patients with Oncogene Mutations.
Cancers (Basel). 2023 Dec 22;16(1):71. doi: 10.3390/cancers16010071.
5
Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy for Refractory Colorectal Liver Metastasis: A Systematic Review.
Cureus. 2023 Dec 6;15(12):e50072. doi: 10.7759/cureus.50072. eCollection 2023 Dec.
6
Efficacy of transarterial chemoembolization with drug-eluting beads combined with systemic chemotherapy and targeted therapy in colorectal cancer liver metastasis.
World J Surg Oncol. 2023 Dec 1;21(1):378. doi: 10.1186/s12957-023-03253-w.
7
Interventional radiological therapies in colorectal hepatic metastases.
Front Oncol. 2023 May 30;13:963966. doi: 10.3389/fonc.2023.963966. eCollection 2023.
8
Colorectal Cancer Liver Metastases: Genomics and Biomarkers with Focus on Local Therapies.
Cancers (Basel). 2023 Mar 9;15(6):1679. doi: 10.3390/cancers15061679.
9
Diagnostic Management of Gastroenteropancreatic Neuroendocrine Neoplasms: Technique Optimization and Tips and Tricks for Radiologists.
Tomography. 2023 Jan 27;9(1):217-246. doi: 10.3390/tomography9010018.
10
Efficacy of Liver Chemoembolization after Prior Cetuximab Monotherapy in Patients with Metastatic Colorectal Cancer.
Cancers (Basel). 2023 Jan 16;15(2):541. doi: 10.3390/cancers15020541.
本文引用的文献
1
Chemoembolization Alone or Associated With Bevacizumab for Therapy of Colorectal Cancer Metastases: Preliminary Results of a Randomized Study.
In Vivo. 2020 Mar-Apr;34(2):683-686. doi: 10.21873/invivo.11824.
2
Toward a better understanding of the mechanism of action for intra-arterial delivery of irinotecan from DC Bead (DEBIRI).
Future Oncol. 2019 Jun;15(17):2053-2068. doi: 10.2217/fon-2019-0071. Epub 2019 Apr 3.
3
Irinotecan-Eluting 75-150-μm Embolics Lobar Chemoembolization in Patients with Colorectal Cancer Liver Metastases: A Prospective Single-Center Phase I Study.
J Vasc Interv Radiol. 2018 Dec;29(12):1646-1653.e5. doi: 10.1016/j.jvir.2018.08.010. Epub 2018 Oct 15.
4
Transarterial Embolization with Small-Size Particles Loaded with Irinotecan for the Treatment of Colorectal Liver Metastases: Results of the MIRACLE III Study.
Cardiovasc Intervent Radiol. 2018 Nov;41(11):1708-1715. doi: 10.1007/s00270-018-2017-x. Epub 2018 Jun 27.
5
Intra-arterial therapies for unresectable and chemorefractory colorectal cancer liver metastases: a systematic review and meta-analysis.
HPB (Oxford). 2018 Oct;20(10):905-915. doi: 10.1016/j.hpb.2018.04.001. Epub 2018 Jun 7.
6
Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation.
Eur J Radiol. 2018 May;102:138-145. doi: 10.1016/j.ejrad.2018.03.015. Epub 2018 Mar 14.
7
Transarterial chemoembolization with DC Bead LUMI™ radiopaque beads for primary liver cancer treatment: preliminary experience.
Future Oncol. 2017 Oct;13(25):2243-2252. doi: 10.2217/fon-2017-0364. Epub 2017 Oct 24.
8
Polyethylene glycol microspheres loaded with irinotecan for arterially directed embolic therapy of metastatic liver cancer.
World J Gastrointest Oncol. 2017 Sep 15;9(9):379-384. doi: 10.4251/wjgo.v9.i9.379.
9
Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: A systematic review.
Surg Oncol. 2017 Sep;26(3):268-275. doi: 10.1016/j.suronc.2017.05.003. Epub 2017 May 22.
10
DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer.
Future Oncol. 2019 Jul;15(20):2349-2360. doi: 10.2217/fon-2017-0025. Epub 2017 Apr 25.
Zotero 插件